Exelixis

EXEL

EXEL
Exelixis Stock Quote
$23.48 -$0.02 -0.1%
Price as of July 2, 2020, 8:00 p.m. EDT View Interactive EXEL Charts

A development-stage biotechnology company dedicated to the discovery and development of novel small molecule therapeutics for the treatment of cancer and other serious diseases.

Interactive Chart


News & Analysis: Exelixis

The Fool has written over 500 articles on Exelixis.

All

Market Moves

Podcasts

Earnings









Is Exelixis a Buy?

Cheap and ready to outperform, this under-the-radar biotech stock could be a winner.